We studied the prevalence and phenotype of family members who manifested both genetic alterations (MEN1 and CDC73); individuals with both alterations presented with a prevalence of hyperparathyroidism of 50% (3/6) compared to 55% (6/11) with MEN1 mutation alone. The gene discussed is MEN1; the disease is hyperparathyroidism.